United States Rabies Vaccine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Rabies Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Rabies Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Rabies Vaccine Overall Market Size
2.1 United States Rabies Vaccine Market Size: 2021 VS 2027
2.2 United States Rabies Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Rabies Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Rabies Vaccine Players in United States Market
3.2 Top United States Rabies Vaccine Companies Ranked by Revenue
3.3 United States Rabies Vaccine Revenue by Companies
3.4 United States Rabies Vaccine Sales by Companies
3.5 United States Rabies Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Rabies Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Rabies Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rabies Vaccine Players in United States Market
3.8.1 List of Tier 1 Rabies Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Rabies Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Rabies Vaccine Market Size Markets, 2021 & 2027
4.1.2 Vero Cell Rabies Vaccine
4.1.3 BHK
4.1.4 Chick Embryo Cell Rabies Vaccine
4.1.5 Others
4.2 By Type - United States Rabies Vaccine Revenue & Forecasts
4.2.1 By Type - United States Rabies Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Rabies Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Rabies Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Rabies Vaccine Sales & Forecasts
4.3.1 By Type - United States Rabies Vaccine Sales, 2016-2021
4.3.2 By Type - United States Rabies Vaccine Sales, 2022-2027
4.3.3 By Type - United States Rabies Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Rabies Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Rabies Vaccine Market Size, 2021 & 2027
5.1.2 Pre-exposure Prophylaxis
5.1.3 Post-exposure Prophylaxis
5.2 By Application - United States Rabies Vaccine Revenue & Forecasts
5.2.1 By Application - United States Rabies Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Rabies Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Rabies Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Rabies Vaccine Sales & Forecasts
5.3.1 By Application - United States Rabies Vaccine Sales, 2016-2021
5.3.2 By Application - United States Rabies Vaccine Sales, 2022-2027
5.3.3 By Application - United States Rabies Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Rabies Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK (Novartis)
6.1.1 GSK (Novartis) Corporation Information
6.1.2 GSK (Novartis) Overview
6.1.3 GSK (Novartis) Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 GSK (Novartis) Rabies Vaccine Product Description
6.1.5 GSK (Novartis) Recent Developments
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Overview
6.2.3 Sanofi-Pasteur Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Sanofi-Pasteur Rabies Vaccine Product Description
6.2.5 Sanofi-Pasteur Recent Developments
6.3 Chengda
6.3.1 Chengda Corporation Information
6.3.2 Chengda Overview
6.3.3 Chengda Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Chengda Rabies Vaccine Product Description
6.3.5 Chengda Recent Developments
6.4 Yisheng
6.4.1 Yisheng Corporation Information
6.4.2 Yisheng Overview
6.4.3 Yisheng Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Yisheng Rabies Vaccine Product Description
6.4.5 Yisheng Recent Developments
6.5 Prcmise
6.5.1 Prcmise Corporation Information
6.5.2 Prcmise Overview
6.5.3 Prcmise Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Prcmise Rabies Vaccine Product Description
6.5.5 Prcmise Recent Developments
6.6 VACN
6.6.1 VACN Corporation Information
6.6.2 VACN Overview
6.6.3 VACN Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 VACN Rabies Vaccine Product Description
6.6.5 VACN Recent Developments
6.7 Changsheng
6.7.1 Changsheng Corporation Information
6.7.2 Changsheng Overview
6.7.3 Changsheng Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 Changsheng Rabies Vaccine Product Description
6.7.5 Changsheng Recent Developments
6.8 BCHT
6.8.1 BCHT Corporation Information
6.8.2 BCHT Overview
6.8.3 BCHT Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.8.4 BCHT Rabies Vaccine Product Description
6.8.5 BCHT Recent Developments
6.9 Hissen
6.9.1 Hissen Corporation Information
6.9.2 Hissen Overview
6.9.3 Hissen Rabies Vaccine Sales and Revenue in United States Market (2016-2021)
6.9.4 Hissen Rabies Vaccine Product Description
6.9.5 Hissen Recent Developments
7 United States Rabies Vaccine Production Capacity, Analysis
7.1 United States Rabies Vaccine Production Capacity, 2016-2027
7.2 Rabies Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Rabies Vaccine Supply Chain Analysis
9.1 Rabies Vaccine Industry Value Chain
9.2 Rabies Vaccine Upstream Market
9.3 Rabies Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Rabies Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Rabies Vaccine in United States Market
Table 2. Top Rabies Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Rabies Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Rabies Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Rabies Vaccine Sales by Companies, (K Units), 2016-2021
Table 6. United States Rabies Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Rabies Vaccine Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Rabies Vaccine Product Type
Table 9. List of Tier 1 Rabies Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Rabies Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Vero Cell Rabies Vaccine
Table 12. Major Manufacturers of BHK
Table 13. By Type - United States Rabies Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Rabies Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Rabies Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Rabies Vaccine Sales (K Units), 2016-2021
Table 17. By Type - United States Rabies Vaccine Sales (K Units), 2022-2027
Table 18. By Application - United States Rabies Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Rabies Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Rabies Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Rabies Vaccine Sales (K Units), 2016-2021
Table 22. By Application - United States Rabies Vaccine Sales (K Units), 2022-2027
Table 23. GSK (Novartis) Corporation Information
Table 24. GSK (Novartis) Description and Major Businesses
Table 25. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. GSK (Novartis) Rabies Vaccine Product
Table 27. GSK (Novartis) Recent Developments
Table 28. Sanofi-Pasteur Corporation Information
Table 29. Sanofi-Pasteur Description and Major Businesses
Table 30. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Sanofi-Pasteur Rabies Vaccine Product
Table 32. Sanofi-Pasteur Recent Developments
Table 33. Chengda Corporation Information
Table 34. Chengda Description and Major Businesses
Table 35. Chengda Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Chengda Rabies Vaccine Product
Table 37. Chengda Recent Developments
Table 38. Yisheng Corporation Information
Table 39. Yisheng Description and Major Businesses
Table 40. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Yisheng Rabies Vaccine Product
Table 42. Yisheng Recent Developments
Table 43. Prcmise Corporation Information
Table 44. Prcmise Description and Major Businesses
Table 45. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Prcmise Rabies Vaccine Product
Table 47. Prcmise Recent Developments
Table 48. VACN Corporation Information
Table 49. VACN Description and Major Businesses
Table 50. VACN Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. VACN Rabies Vaccine Product
Table 52. VACN Recent Developments
Table 53. Changsheng Corporation Information
Table 54. Changsheng Description and Major Businesses
Table 55. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Changsheng Rabies Vaccine Product
Table 57. Changsheng Recent Developments
Table 58. BCHT Corporation Information
Table 59. BCHT Description and Major Businesses
Table 60. BCHT Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. BCHT Rabies Vaccine Product
Table 62. BCHT Recent Developments
Table 63. Hissen Corporation Information
Table 64. Hissen Description and Major Businesses
Table 65. Hissen Rabies Vaccine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Hissen Rabies Vaccine Product
Table 67. Hissen Recent Developments
Table 68. Rabies Vaccine Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 69. United States Rabies Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Rabies Vaccine Market Opportunities & Trends in United States Market
Table 71. Rabies Vaccine Market Drivers in United States Market
Table 72. Rabies Vaccine Market Restraints in United States Market
Table 73. Rabies Vaccine Raw Materials
Table 74. Rabies Vaccine Raw Materials Suppliers in United States Market
Table 75. Typical Rabies Vaccine Downstream
Table 76. Rabies Vaccine Downstream Clients in United States Market
Table 77. Rabies Vaccine Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Rabies Vaccine Product Picture
Figure 2. Rabies Vaccine Segment by Type
Figure 3. Rabies Vaccine Segment by Application
Figure 4. United States Rabies Vaccine Market Overview: 2020
Figure 5. United States Rabies Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Rabies Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Rabies Vaccine Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rabies Vaccine Revenue in 2020
Figure 9. Vero Cell Rabies Vaccine Product Picture
Figure 10. BHK Product Picture
Figure 11. Chick Embryo Cell Rabies Vaccine Product Picture
Figure 12. Others Product Picture
Figure 13. By Type - United States Rabies Vaccine Sales Market Share, 2016-2027
Figure 14. By Type - United States Rabies Vaccine Revenue Market Share, 2016-2027
Figure 15. By Type - United States Rabies Vaccine Price (USD/Unit), 2016-2027
Figure 16. Pre-exposure Prophylaxis
Figure 17. Post-exposure Prophylaxis
Figure 18. By Application - United States Rabies Vaccine Sales Market Share, 2016-2027
Figure 19. By Application - United States Rabies Vaccine Revenue Market Share, 2016-2027
Figure 20. By Application - United States Rabies Vaccine Price (USD/Unit), 2016-2027
Figure 21. GSK (Novartis) Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Sanofi-Pasteur Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Chengda Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Yisheng Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Prcmise Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. VACN Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Changsheng Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. BCHT Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Hissen Rabies Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. United States Rabies Vaccine Production Capacity (K Units), 2016-2027
Figure 31. Rabies Vaccine Industry Value Chain
Figure 32. Marketing Channels